Business Description
DOD Biotech PCL
ISIN : TH8569010003
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.53 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -2.41 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.57 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.2 | |||||
3-Year EBITDA Growth Rate | -31.5 | |||||
3-Year EPS without NRI Growth Rate | -65.6 | |||||
3-Year FCF Growth Rate | -70.6 | |||||
3-Year Book Growth Rate | -7.4 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.98 | |||||
9-Day RSI | 43.91 | |||||
14-Day RSI | 54.3 | |||||
6-1 Month Momentum % | -29.08 | |||||
12-1 Month Momentum % | -50.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.95 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 109.14 | |||||
Days Sales Outstanding | 44.97 | |||||
Days Payable | 82.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | 3.91 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33.5 | |||||
Operating Margin % | -2.69 | |||||
Net Margin % | -21.35 | |||||
FCF Margin % | 7.08 | |||||
ROE % | -14.9 | |||||
ROA % | -10.91 | |||||
ROIC % | -1.84 | |||||
3-Year ROIIC % | 289.89 | |||||
ROC (Joel Greenblatt) % | -13.4 | |||||
ROCE % | -11.92 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 16.69 | |||||
PS Ratio | 1.78 | |||||
PB Ratio | 1.42 | |||||
Price-to-Tangible-Book | 1.5 | |||||
Price-to-Free-Cash-Flow | 24.78 | |||||
Price-to-Operating-Cash-Flow | 22.04 | |||||
EV-to-EBIT | -9.93 | |||||
EV-to-EBITDA | -22.57 | |||||
EV-to-Revenue | 1.88 | |||||
EV-to-FCF | 28.18 | |||||
Price-to-Net-Current-Asset-Value | 8.24 | |||||
Earnings Yield (Greenblatt) % | -10.07 | |||||
FCF Yield % | 3.99 | |||||
Forward Rate of Return (Yacktman) % | -2.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
DOD Biotech PCL Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ฿) | 710.262 | ||
EPS (TTM) (฿) | -0.336 | ||
Beta | 2.11 | ||
Volatility % | 65.83 | ||
14-Day RSI | 54.3 | ||
14-Day ATR (฿) | 0.137822 | ||
20-Day SMA (฿) | 2.931 | ||
12-1 Month Momentum % | -50.25 | ||
52-Week Range (฿) | 1.3 - 4.04 | ||
Shares Outstanding (Mil) | 450.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
DOD Biotech PCL Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
DOD Biotech PCL Stock Events
Event | Date | Price(฿) | ||
---|---|---|---|---|
No Event Data |
DOD Biotech PCL Frequently Asked Questions
What is DOD Biotech PCL(BKK:DOD)'s stock price today?
When is next earnings date of DOD Biotech PCL(BKK:DOD)?
Does DOD Biotech PCL(BKK:DOD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |